AQP5-AS1 and renal carcinoma: In vitro functional experiments showed that MIAC polypeptide dose-dependently inhibited the proliferation (Fig. 6A) and migration (Fig. 6B) of renal cancer cells, promoted S phase and G2 phase arrest (Fig. 6C) and cell apoptosis (Fig. 6D).